Cassava Sciences, Inc. Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - SAVA
Portfolio Pulse from
Cassava Sciences, Inc. is under investigation by Levi & Korsinsky for potential securities law violations after announcing that its Phase 3 ReThink-ALZ study did not meet key endpoints.
November 28, 2024 | 3:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Cassava Sciences is being investigated for potential securities law violations following the failure of its Phase 3 trial for simufilam to meet key endpoints.
The investigation by Levi & Korsinsky and the failure of the Phase 3 trial are likely to negatively impact investor confidence and the stock price of Cassava Sciences in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100